Description
This section will provide an overview and understanding of:
- Key stakeholders in the Spanish retail & hospital market
- Pricing and Reimbursement timelines in Spain
- Key determinants influencing the reimbursement status and pricing potential of an asset
- Recent trends within the national HTA body assessments
- Overview of regional HTA bodies and their growing influence on the Spanish pricing and reimbursement landscape
- Illustrative analogue cases in oncology, orphan drugs and CVDs, showcasing assessment and pricing trends for specific therapeutic areas
